GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Axogen Inc (NAS:AXGN) » Definitions » Shiller PE Ratio

Axogen (Axogen) Shiller PE Ratio : (As of May. 02, 2024)


View and export this data going back to 1986. Start your Free Trial

What is Axogen Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Axogen Shiller PE Ratio Historical Data

The historical data trend for Axogen's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Axogen Shiller PE Ratio Chart

Axogen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Axogen Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Axogen's Shiller PE Ratio

For the Medical Devices subindustry, Axogen's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Axogen's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Axogen's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Axogen's Shiller PE Ratio falls into.



Axogen Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Axogen's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Axogen's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.09/129.4194*129.4194
=-0.090

Current CPI (Dec. 2023) = 129.4194.

Axogen Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -0.240 99.695 -0.312
201406 -0.210 100.560 -0.270
201409 -0.190 100.428 -0.245
201412 -0.350 99.070 -0.457
201503 -0.160 99.621 -0.208
201506 -0.130 100.684 -0.167
201509 -0.110 100.392 -0.142
201512 -0.120 99.792 -0.156
201603 -0.120 100.470 -0.155
201606 -0.090 101.688 -0.115
201609 -0.080 101.861 -0.102
201612 -0.170 101.863 -0.216
201703 -0.110 102.862 -0.138
201706 -0.060 103.349 -0.075
201709 -0.060 104.136 -0.075
201712 -0.070 104.011 -0.087
201803 -0.160 105.290 -0.197
201806 -0.200 106.317 -0.243
201809 -0.110 106.507 -0.134
201812 -0.130 105.998 -0.159
201903 -0.240 107.251 -0.290
201906 -0.180 108.070 -0.216
201909 -0.140 108.329 -0.167
201912 -0.180 108.420 -0.215
202003 -0.210 108.902 -0.250
202006 -0.200 108.767 -0.238
202009 -0.040 109.815 -0.047
202012 -0.150 109.897 -0.177
202103 -0.160 111.754 -0.185
202106 -0.190 114.631 -0.215
202109 -0.170 115.734 -0.190
202112 -0.120 117.630 -0.132
202203 -0.270 121.301 -0.288
202206 -0.180 125.017 -0.186
202209 -0.100 125.227 -0.103
202212 -0.130 125.222 -0.134
202303 -0.170 127.348 -0.173
202306 -0.160 128.729 -0.161
202309 -0.100 129.860 -0.100
202312 -0.090 129.419 -0.090

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Axogen  (NAS:AXGN) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Axogen Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Axogen's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Axogen (Axogen) Business Description

Traded in Other Exchanges
Address
13631 Progress Boulevard, Suite 400, Alachua, FL, USA, 32615
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
Executives
Peter J Mariani officer: Chief Financial Officer C/O GUIDANT CORP, 111 MONUMENT CIRCLE #2900, INDIANAPOLIS IN 46204-5129
Amy Mcbride Wendell director COVIDIEN LTD., 15 HAMPSHIRE STREET, MANSFIELD MA 02048
Burke William P. Mr. director HAEMONETICS CORPORATION, 400 WOOD ROAD, BRAINTREE MA 02184
Guido J Neels director C/O GUIDANT CORP, 111 MONUMENT CIRCLE #2900, INDIANAPOLIS IN 46204-5129
Gregory Gene Freitag director 13631 PROGRESS BLVD., ALACHUA FL 32615
Marc A Began officer: EVP & General Counsel C/O ABIOMED, INC., 22 CHERRY HILL DRIVE, DANVERS MA 01923
Joseph A. Tyndall director 13631 PROGRESS BLVD., SUITE 400, ALACHUA FL 32615
John Johnson director DENDREON CORPORATION, 1301 2ND AVENUE, SEATTLE WA 98101
Karen L. Zaderej director, officer: CEO AXOGEN INC., 13859 PROGRESS BLVD, SUITE 100, ALACHUA FL 32615
Michael Patrick Donovan officer: VP Operations C/O AXOGEN, INC., 13631 PROGRESS BLVD. SUITE 400, ALACHUA FL 32615
Maria D. Martinez officer: Chief Human Resources Officer C/O AXOGEN INC., 13631 PROGRESS BLVD, SUITE 400, ALACHUA FL 32615
Paul Thomas director ONE MILLENNIUM WAY, BRANCHBURG NJ 08876
Alan M Levine director C/O AXOGEN, INC., 13631 PROGRESS BLVD. - SUITE 400, ALACHUA FL 32615
Mark Stephen Gold director 13859 PROGRESS BLVD SUITE 100, ALACHUA FL 32615
Quentin S. Blackford director 7475 LUSK BLVD., SAN DIEGO CA 92121